Unidade Local De Saude Do Alto Minho E.P.E.

Az itteni vizsgálatok

Miről szól a helyszín 22 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek

• Arthritis psoriatica7 vizsgálat
• Pikkelysömör4 vizsgálat
• Sjögren-szindróma4 vizsgálat
• Szisztémás szklerózis (szkleroderma)4 vizsgálat
• Rheumatoid arthritis3 vizsgálat
• Lupus (SLE)2 vizsgálat
• Colitis ulcerosa1 vizsgálat
• Osteoarthritis1 vizsgálat

Fázis

• 3. fázis16 vizsgálat
• 2. fázis5 vizsgálat
• 4. fázis1 vizsgálat

Állapot

• Fut, nem toboroz8 vizsgálat
• Lezárult8 vizsgálat
• Még nem toboroz3 vizsgálat
• Toboroz3 vizsgálat

Fő szponzor

• AbbVie5 vizsgálat
• Horizon Therapeutics Ireland Designated Activity Company4 vizsgálat
• Amgen3 vizsgálat
• Janssen Research & Development, LLC2 vizsgálat
• MoonLake Immunotherapeutics AG2 vizsgálat
• és még 5

Futó vizsgálatok

• Toboroz

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

  NCT07286058· 3. fázis· Takeda· Forrás

• Toboroz

  A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

  NCT07438496· 3. fázis· Janssen Research & Development, LLC· Forrás

• Még nem toboroz

  A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with psoriatic arthritis (PsA)

  2025-522471-28-00· 3. fázis· MoonLake Immunotherapeutics AG· Forrás

• Toboroz

  RANDOMISED, MULTICENTRE, DOUBLE-BLIND CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF MONTELUKAST VS. PLACEBO IN PATIENTS WITH EROSIVE/INFLAMMATORY OSTEOARTHRITIS OF THE HANDS. MOTHER Study.

  2025-521802-17-00· 3. fázis· Farmalider S.A.· Forrás

• Fut, nem toboroz

  A study to investigate the efficacy and safety of subcutaneous sonelokimab versus placebo in participants aged 18 years and over with active psoriatic arthritis who are naive to biologic DMARDs

  2024-516213-20-00· 3. fázis· MoonLake Immunotherapeutics AG· Forrás

• Fut, nem toboroz

  A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

  NCT06671483· 3. fázis· Takeda· Forrás

• Toboroz

  A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

  NCT06747949· 3. fázis· Amgen· Forrás

• Toboroz

  Platform Clinical Study for Conquering Scleroderma

  NCT06195072· 2. fázis· Scleroderma Research Foundation, Inc.· Forrás

• Fut, nem toboroz

  Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

  NCT05843643· 3. fázis· AbbVie· Forrás

• Toboroz

  Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis

  NCT04804553· 3. fázis· Amgen· Forrás

• Fut, nem toboroz

  A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)

  NCT03671148· 3. fázis· AbbVie· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)

  NCT03006068· 3. fázis· AbbVie· Forrás

• Fut, nem toboroz

  A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate

  NCT02629159· 3. fázis· AbbVie· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Arthritis psoriatica3 toboroz
• Lupus (SLE)1 toboroz
• Osteoarthritis1 toboroz
• Pikkelysömör1 toboroz
• Szisztémás szklerózis (szkleroderma)1 toboroz

Lezárt vizsgálatok

• Lezárult

  A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjögren’s Syndrome

  NCT06312020· 2. fázis· Horizon Therapeutics Ireland Designated Activity Company· Forrás

• Lezárult

  Phase IIa Proof-of-Concept Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients with Rheumatoid Arthritis

  2023-510258-17-00· 2. fázis· Solfarcos Solucoes Farmaceuticas E Cosmeticas Lda.· Forrás

• Lezárult

  A study to find how well Dazodalibep works and how safe it is in participants with Sjögren’s Syndrome

  2023-503923-24-00· 3. fázis· Horizon Therapeutics Ireland Designated Activity Company· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

  NCT06104124· 3. fázis· Amgen· Forrás

• Lezárult

  Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

  NCT05814627· 3. fázis· AbbVie· Forrás

• Lezárult

  A Open-label Study to Evaluate the Efficacy, Safety, Tolerability of HZN-825 in Patients with Diffuse Cutaneous Systemic Sclerosis

  NCT04781543· 2. fázis· Horizon Therapeutics Ireland Designated Activity Company· Forrás

• Lezárult

  A Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients with Diffuse Cutaneous Systemic Sclerosis

  2023-509782-20-00· 2. fázis· Horizon Therapeutics Ireland Designated Activity Company· Forrás

• Fut, nem toboroz

  A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease

  NCT04929210· 4. fázis· Janssen Research & Development, LLC· Forrás